Jaguar Health (JAGX) Intangibles (2017 - 2026)
Jaguar Health (JAGX) posted quarterly Intangibles of $11.6 million for Q1 2026, down 12.55% year-over-year from $13.2 million in Q1 2025, and down 27.89% quarter-over-quarter from $16.0 million in Q4 2025.
Jaguar Health (JAGX) Intangibles (2017 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Intangibles for 10 consecutive years, with $11.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles fell 12.55% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $11.6 million (down 12.55% YoY), while the FY2025 annual figure was $16.0 million, down 13.3% from the prior year.
- Intangibles retreated to $11.6 million in Q1 2026 per JAGX's latest filing, from $16.0 million in the prior quarter.
- Across five years, Intangibles topped out at $23.0 million in Q2 2022 and bottomed at $11.6 million in Q1 2026.
- Historically, Intangibles has averaged $18.1 million across 5 years, with a median of $18.5 million in 2024.
- Annual changes were most pronounced in 2024 — Intangibles climbed 17.14% — and 2025, when it sank 34.33%.
- Jaguar Health's Intangibles stood at $22.4 million in 2022, then fell by 10.35% to $20.1 million in 2023, then retreated by 8.14% to $18.5 million in 2024, then retreated by 13.3% to $16.0 million in 2025, then retreated by 27.89% to $11.6 million in 2026.
- Business Quant data shows JAGX's Intangibles at $11.6 million in Q1 2026, $16.0 million in Q4 2025, and $17.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 15.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.55 Mn |
| Dec 31, 2025 | 16.02 Mn |
| Sep 30, 2025 | 17.29 Mn |
| Jun 30, 2025 | 12.75 Mn |
| Mar 31, 2025 | 13.21 Mn |
| Dec 31, 2024 | 18.48 Mn |
| Sep 30, 2024 | 18.95 Mn |
| Jun 30, 2024 | 19.41 Mn |
| Mar 31, 2024 | 14.83 Mn |
| Dec 31, 2023 | 20.12 Mn |
| Sep 30, 2023 | 16.17 Mn |
| Jun 30, 2023 | 21.46 Mn |
| Mar 31, 2023 | 17.15 Mn |
| Dec 31, 2022 | 22.44 Mn |
| Sep 30, 2022 | 22.56 Mn |
| Jun 30, 2022 | 22.99 Mn |
| Mar 31, 2022 | 22.23 Mn |
| Dec 31, 2021 | 22.65 Mn |
| Sep 30, 2021 | 23.07 Mn |
| Jun 30, 2021 | 23.49 Mn |